Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca sees R&D restructuring to result in $1.4B in charges
AstraZeneca sees R&D restructuring to result in $1.4B in charges
AstraZeneca sees R&D restructuring to result in $1.4B in charges
Submitted by
admin
on March 18, 2013 - 11:00am
Source:
Yahoo/Fly on the Wall
News Tags:
R&D
AstraZeneca
restructuring
Headline:
AstraZeneca sees R&D restructuring to result in $1.4B in charges
Do Not Allow Advertisers to Use My Personal information
